The Department of Health and Human Services (HHS) appealed the U.S. District Court for the District of Columbia’s decision to enjoin payment cuts for 340B drugs under the 2018 Outpatient…
On Monday, March 11, 2019, HRSA’s Office of Pharmacy Affairs will be hosting a webinar for covered entities that will provide an overview of the secure pricing component of the…
This is a reminder that the 340B annual recertification period for HRSA grantees ends on February 25, 2019. Recertification must be completed through the 340B OPAIS database. The Primary Contact…
In a letter dated February 11, 2019, CVS Caremark announced that it will not implement its plan to reduce payment rates for pharmacies owned by 340B covered entities. These cuts…
Earlier this week, CVS Caremark issued letters to 340B covered entity owned pharmacies announcing that it has delayed the scheduled cuts in reimbursement rates until April 1, 2019. In November…
On December 20th, the national hospital groups that brought a lawsuit against HHS over the continued delay of the implementation date of the 340B Ceiling Price and Manufacturer Civil Monetary…
On January 7, California Gov. Gavin Newsom signed an executive order instructing Medi-Cal to transition all pharmacy services for Medi-Cal managed care to fee-for-service (FFS) by January 2021. The directive…
In December, the Health Resources and Services Administration (HRSA) released a report affirming what RWCs know to be true – Ryan White HIV/AIDS providers are achieving record levels of viral…
On December 27, 2018, the U.S. District Court for the District of Columbia struck down the portion of the 2018 OPPS rule that cut Medicare Part B drug reimbursement to…
RWC-340B was proud to exhibit at the 2018 National Ryan White Conference on HIV Care & Treatment last week in Washington, DC. This was the first year that RWC-340B exhibited…